![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 7240 |
FusionGeneSummary for CIITA_PRDM16 |
![]() |
Fusion gene information | Fusion gene name: CIITA_PRDM16 | Fusion gene ID: 7240 | Hgene | Tgene | Gene symbol | CIITA | PRDM16 | Gene ID | 4261 | 63976 |
Gene name | class II major histocompatibility complex transactivator | PR/SET domain 16 | |
Synonyms | C2TA|CIITAIV|MHC2TA|NLRA | CMD1LL|KMT8F|LVNC8|MEL1|PFM13 | |
Cytomap | 16p13.13 | 1p36.32 | |
Type of gene | protein-coding | protein-coding | |
Description | MHC class II transactivatorMHC class II transactivator type IMHC class II transactivator type IIINLR family, acid domain containingnucleotide-binding oligomerization domain, leucine rich repeat and acid domain containing | PR domain zinc finger protein 16MDS1/EVI1-like gene 1PR domain 16PR domain containing 16transcription factor MEL1 | |
Modification date | 20180523 | 20180522 | |
UniProtAcc | P33076 | Q9HAZ2 | |
Ensembl transtripts involved in fusion gene | ENST00000324288, ENST00000381835, ENST00000537380, | ENST00000511072, ENST00000442529, ENST00000378398, ENST00000441472, ENST00000378391, ENST00000514189, ENST00000270722, ENST00000512462, | |
Fusion gene scores | * DoF score | 3 X 3 X 3=27 | 5 X 4 X 4=80 |
# samples | 3 | 5 | |
** MAII score | log2(3/27*10)=0.15200309344505 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(5/80*10)=-0.678071905112638 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: CIITA [Title/Abstract] AND PRDM16 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | CIITA | GO:0034341 | response to interferon-gamma | 19041327 |
Hgene | CIITA | GO:0045345 | positive regulation of MHC class I biosynthetic process | 20639463 |
Hgene | CIITA | GO:0045892 | negative regulation of transcription, DNA-templated | 19041327 |
Hgene | CIITA | GO:0045893 | positive regulation of transcription, DNA-templated | 19041327 |
Hgene | CIITA | GO:0045944 | positive regulation of transcription by RNA polymerase II | 20639463 |
Hgene | CIITA | GO:0046677 | response to antibiotic | 107465 |
Tgene | PRDM16 | GO:0000122 | negative regulation of transcription by RNA polymerase II | 19049980 |
Tgene | PRDM16 | GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway | 14656887 |
Tgene | PRDM16 | GO:0045892 | negative regulation of transcription, DNA-templated | 12816872 |
Tgene | PRDM16 | GO:0045893 | positive regulation of transcription, DNA-templated | 25578880 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | RV | DLBC | TCGA-GS-A9TZ-01A | CIITA | chr16 | 10971239 | + | PRDM16 | chr1 | 3301716 | + |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
Frame-shift | ENST00000324288 | ENST00000511072 | CIITA | chr16 | 10971239 | + | PRDM16 | chr1 | 3301716 | + |
Frame-shift | ENST00000324288 | ENST00000442529 | CIITA | chr16 | 10971239 | + | PRDM16 | chr1 | 3301716 | + |
Frame-shift | ENST00000324288 | ENST00000378398 | CIITA | chr16 | 10971239 | + | PRDM16 | chr1 | 3301716 | + |
Frame-shift | ENST00000324288 | ENST00000441472 | CIITA | chr16 | 10971239 | + | PRDM16 | chr1 | 3301716 | + |
Frame-shift | ENST00000324288 | ENST00000378391 | CIITA | chr16 | 10971239 | + | PRDM16 | chr1 | 3301716 | + |
Frame-shift | ENST00000324288 | ENST00000514189 | CIITA | chr16 | 10971239 | + | PRDM16 | chr1 | 3301716 | + |
Frame-shift | ENST00000324288 | ENST00000270722 | CIITA | chr16 | 10971239 | + | PRDM16 | chr1 | 3301716 | + |
5CDS-3UTR | ENST00000324288 | ENST00000512462 | CIITA | chr16 | 10971239 | + | PRDM16 | chr1 | 3301716 | + |
Frame-shift | ENST00000381835 | ENST00000511072 | CIITA | chr16 | 10971239 | + | PRDM16 | chr1 | 3301716 | + |
Frame-shift | ENST00000381835 | ENST00000442529 | CIITA | chr16 | 10971239 | + | PRDM16 | chr1 | 3301716 | + |
Frame-shift | ENST00000381835 | ENST00000378398 | CIITA | chr16 | 10971239 | + | PRDM16 | chr1 | 3301716 | + |
Frame-shift | ENST00000381835 | ENST00000441472 | CIITA | chr16 | 10971239 | + | PRDM16 | chr1 | 3301716 | + |
Frame-shift | ENST00000381835 | ENST00000378391 | CIITA | chr16 | 10971239 | + | PRDM16 | chr1 | 3301716 | + |
Frame-shift | ENST00000381835 | ENST00000514189 | CIITA | chr16 | 10971239 | + | PRDM16 | chr1 | 3301716 | + |
Frame-shift | ENST00000381835 | ENST00000270722 | CIITA | chr16 | 10971239 | + | PRDM16 | chr1 | 3301716 | + |
5CDS-3UTR | ENST00000381835 | ENST00000512462 | CIITA | chr16 | 10971239 | + | PRDM16 | chr1 | 3301716 | + |
3UTR-3CDS | ENST00000537380 | ENST00000511072 | CIITA | chr16 | 10971239 | + | PRDM16 | chr1 | 3301716 | + |
3UTR-3CDS | ENST00000537380 | ENST00000442529 | CIITA | chr16 | 10971239 | + | PRDM16 | chr1 | 3301716 | + |
3UTR-3CDS | ENST00000537380 | ENST00000378398 | CIITA | chr16 | 10971239 | + | PRDM16 | chr1 | 3301716 | + |
3UTR-3CDS | ENST00000537380 | ENST00000441472 | CIITA | chr16 | 10971239 | + | PRDM16 | chr1 | 3301716 | + |
3UTR-3CDS | ENST00000537380 | ENST00000378391 | CIITA | chr16 | 10971239 | + | PRDM16 | chr1 | 3301716 | + |
3UTR-3CDS | ENST00000537380 | ENST00000514189 | CIITA | chr16 | 10971239 | + | PRDM16 | chr1 | 3301716 | + |
3UTR-3CDS | ENST00000537380 | ENST00000270722 | CIITA | chr16 | 10971239 | + | PRDM16 | chr1 | 3301716 | + |
3UTR-3UTR | ENST00000537380 | ENST00000512462 | CIITA | chr16 | 10971239 | + | PRDM16 | chr1 | 3301716 | + |
Top |
FusionProtFeatures for CIITA_PRDM16 |
![]() |
Hgene | Tgene |
CIITA | PRDM16 |
Essential for transcriptional activity of the HLA classII promoter; activation is via the proximal promoter. No DNAbinding of in vitro translated CIITA was detected. May act in acoactivator-like fashion through protein-protein interactions bycontacting factors binding to the proximal MHC class II promoter,to elements of the transcription machinery, or both. Alternativelyit may activate HLA class II transcription by modifying proteinsthat bind to the MHC class II promoter. Also mediates enhanced MHCclass I transcription; the promoter element requirements forCIITA-mediated transcription are distinct from those ofconstitutive MHC class I transcription, and CIITA can functionallyreplace TAF1 at these genes. Exhibits intrinsic GTP-stimulatedacetyltransferase activity. Exhibits serine/threonine proteinkinase activity: can phosphorylate the TFIID component TAF7, theRAP74 subunit of the general transcription factor TFIIF, histoneH2B at 'Ser-37' and other histones (in vitro).{ECO:0000269|PubMed:11172716, ECO:0000269|PubMed:16600381,ECO:0000269|PubMed:17493635, ECO:0000269|PubMed:24036077}. | Binds DNA and functions as a transcriptional regulator.Functions in the differentiation of brown adipose tissue (BAT)which is specialized in dissipating chemical energy in the form ofheat in response to cold or excess feeding while white adiposetissue (WAT) is specialized in the storage of excess energy andthe control of systemic metabolism. Together with CEBPB, regulatesthe differentiation of myoblastic precursors into brown adiposecells. Functions also as a repressor of TGF-beta signaling.Isoform 4 may regulate granulocytes differentiation.{ECO:0000269|PubMed:12816872, ECO:0000269|PubMed:14656887,ECO:0000269|PubMed:19049980}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for CIITA_PRDM16 |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for CIITA_PRDM16 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
CIITA | NCOA1, RFXANK, RFX5, XPO1, MAPK1, CDK1, MAPK3, HDAC2, HDAC1, SMARCA4, HDAC4, HDAC5, SIN3B, GSK3B, PSMC5, PSMC2, PSMC3, GTF2B, TAF9, CUL3, PPARG, EP300, EP400, TBP, TRIM22, PML, CCNT1 | PRDM16 | SMAD2, SMAD3, SKI, TFAP4, SPDEF |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for CIITA_PRDM16 |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for CIITA_PRDM16 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | CIITA | C2931418 | Bare lymphocyte syndrome 2 | 2 | CTD_human;ORPHANET;UNIPROT |
Hgene | CIITA | C0001403 | Addison Disease | 1 | CTD_human |
Tgene | PRDM16 | C0149931 | Migraine Disorders | 1 | CTD_human |
Tgene | PRDM16 | C3809288 | LEFT VENTRICULAR NONCOMPACTION 8 | 1 | ORPHANET;UNIPROT |